Technical Analysis for BLPH - Bellerophon Therapeutics, Inc.

Grade Last Price % Change Price Change
grade B 14.18 1.79% 0.25
BLPH closed up 1.79 percent on Friday, May 29, 2020, on 19 percent of normal volume. It was able to find support at its 50 day moving average. Note that the stock is in oversold territory based on its Slow Stochastic indicator (14, 3, 3) -- sideways movement or a bounce should not be unexpected.

Trend Table & Recent Signals

ADX Long Term Intermediate Term Short Term
Strong Up Up Down
Historical BLPH trend table...

Date Alert Name Type % Chg
50 DMA Support Bullish 0.00%
Stochastic Buy Signal Bullish 0.00%
Narrow Range Bar Range Contraction 0.00%
Wide Bands Range Expansion 0.00%
Oversold Stochastic Weakness 0.00%
MACD Bearish Centerline Cross Bearish 1.79%
50 DMA Support Bullish 1.79%
Narrow Range Bar Range Contraction 1.79%
Wide Bands Range Expansion 1.79%
Oversold Stochastic Weakness 1.79%

Free Daily (Stock) Chart Reading

Let us help you stay on top of your investments. We will alert you to important technical developments on your portfolio & watchlist.
Configure default chart indicators
Basic chart:

Profile

Bellerophon Therapeutics LLC, a clinical-stage therapeutics company, focuses on the development of various products for the treatment of cardiopulmonary and cardiac diseases. Its product candidates include INOpulse for the treatment of pulmonary arterial hypertension, as well as to treat pulmonary hypertension associated with chronic obstructive pulmonary diseases; and bioabsorbable cardiac matrix, a medical device for the prevention of congestive heart failure. The company was formerly known as Ikaria Development LLC and changed its name to Bellerophon Therapeutics LLC in January 2014. Bellerophon Therapeutics LLC was founded in 2009 and is based in Hampton, New Jersey.
Anatomy Heart Failure Pulmonary Arterial Hypertension Cardiovascular Diseases Hypertension Aging Associated Diseases Cardiovascular System Pulmonary Hypertension Pulmonology Respiratory Disease Chronic Obstructive Pulmonary Diseases Congestive Heart Failure

Is BLPH a Buy, Sell or Hold?

Indicator Bull Case Neutral / Hold Bear Case
50 DMA
200 DMA
ADX Trend
Oversold / Overbought
Relative Strength

Indicators

Indicator Value
52 Week High 26.0
52 Week Low 3.1859
Average Volume 720,532
200-Day Moving Average 8.51
50-Day Moving Average 13.94
20-Day Moving Average 15.97
10-Day Moving Average 14.44
Average True Range 1.60
ADX 29.07
+DI 25.54
-DI 22.68
Chandelier Exit (Long, 3 ATRs ) 16.47
Chandelier Exit (Short, 3 ATRs ) 17.64
Upper Bollinger Band 19.82
Lower Bollinger Band 12.11
Percent B (%b) 0.27
BandWidth 48.27
MACD Line -0.07
MACD Signal Line 0.42
MACD Histogram -0.4914
Fundamentals Value
Market Cap 503.55 Million
Num Shares 35.5 Million
EPS -1.39
Price-to-Earnings (P/E) Ratio -10.20
Price-to-Sales 0.00
Price-to-Book 0.00
PEG Ratio 0.00
Dividend 0.00
Dividend Yield 0.00%
Pivot Point Level Traditional / Classic Fibonacci Demark Woodie Camarilla
Resistance 4 (R4) 15.31
Resistance 3 (R3) 15.20 14.71 15.12
Resistance 2 (R2) 14.71 14.43 14.77 15.05
Resistance 1 (R1) 14.45 14.25 14.58 14.56 14.99
Pivot Point 13.96 13.96 14.03 14.02 13.96
Support 1 (S1) 13.70 13.68 13.83 13.81 13.37
Support 2 (S2) 13.21 13.50 13.27 13.31
Support 3 (S3) 12.95 13.21 13.24
Support 4 (S4) 13.06